S&P 500   5,042.85 (-0.37%)
DOW   37,763.90 (+0.08%)
QQQ   431.84 (+0.18%)
AAPL   172.13 (-0.32%)
MSFT   417.14 (+0.85%)
META   502.41 (+0.44%)
GOOGL   154.80 (-0.04%)
AMZN   184.36 (+0.40%)
TSLA   156.86 (-2.86%)
NVDA   878.05 (+2.10%)
AMD   163.11 (+1.74%)
NIO   3.80 (-2.31%)
BABA   69.84 (-1.10%)
T   16.09 (-0.92%)
F   12.17 (-0.49%)
MU   120.00 (-1.13%)
GE   154.98 (+0.83%)
CGC   6.84 (-2.01%)
DIS   113.58 (+0.56%)
AMC   2.53 (+2.43%)
PFE   25.93 (+0.08%)
PYPL   63.40 (-0.17%)
XOM   118.84 (-0.70%)
S&P 500   5,042.85 (-0.37%)
DOW   37,763.90 (+0.08%)
QQQ   431.84 (+0.18%)
AAPL   172.13 (-0.32%)
MSFT   417.14 (+0.85%)
META   502.41 (+0.44%)
GOOGL   154.80 (-0.04%)
AMZN   184.36 (+0.40%)
TSLA   156.86 (-2.86%)
NVDA   878.05 (+2.10%)
AMD   163.11 (+1.74%)
NIO   3.80 (-2.31%)
BABA   69.84 (-1.10%)
T   16.09 (-0.92%)
F   12.17 (-0.49%)
MU   120.00 (-1.13%)
GE   154.98 (+0.83%)
CGC   6.84 (-2.01%)
DIS   113.58 (+0.56%)
AMC   2.53 (+2.43%)
PFE   25.93 (+0.08%)
PYPL   63.40 (-0.17%)
XOM   118.84 (-0.70%)
S&P 500   5,042.85 (-0.37%)
DOW   37,763.90 (+0.08%)
QQQ   431.84 (+0.18%)
AAPL   172.13 (-0.32%)
MSFT   417.14 (+0.85%)
META   502.41 (+0.44%)
GOOGL   154.80 (-0.04%)
AMZN   184.36 (+0.40%)
TSLA   156.86 (-2.86%)
NVDA   878.05 (+2.10%)
AMD   163.11 (+1.74%)
NIO   3.80 (-2.31%)
BABA   69.84 (-1.10%)
T   16.09 (-0.92%)
F   12.17 (-0.49%)
MU   120.00 (-1.13%)
GE   154.98 (+0.83%)
CGC   6.84 (-2.01%)
DIS   113.58 (+0.56%)
AMC   2.53 (+2.43%)
PFE   25.93 (+0.08%)
PYPL   63.40 (-0.17%)
XOM   118.84 (-0.70%)
S&P 500   5,042.85 (-0.37%)
DOW   37,763.90 (+0.08%)
QQQ   431.84 (+0.18%)
AAPL   172.13 (-0.32%)
MSFT   417.14 (+0.85%)
META   502.41 (+0.44%)
GOOGL   154.80 (-0.04%)
AMZN   184.36 (+0.40%)
TSLA   156.86 (-2.86%)
NVDA   878.05 (+2.10%)
AMD   163.11 (+1.74%)
NIO   3.80 (-2.31%)
BABA   69.84 (-1.10%)
T   16.09 (-0.92%)
F   12.17 (-0.49%)
MU   120.00 (-1.13%)
GE   154.98 (+0.83%)
CGC   6.84 (-2.01%)
DIS   113.58 (+0.56%)
AMC   2.53 (+2.43%)
PFE   25.93 (+0.08%)
PYPL   63.40 (-0.17%)
XOM   118.84 (-0.70%)

Musk's company aims to soon test brain implant in people


Elon Musk, Tesla CEO, attends the opening of the Tesla factory Berlin Brandenburg in Gruenheide, Germany, March 22, 2022. Musk said during a presentation Wednesday, Dec. 1, 2022, that his Neuralink company is seeking permission to test its brain implant in people soon. Musk’s Neuralink is one of many groups working on linking brains to computers, efforts aimed at helping treat brain disorders, overcoming brain injuries and other applications. (Patrick Pleul/Pool via AP, File)

Tech billionaire Elon Musk said his Neuralink company is seeking permission to test its brain implant in people soon.

In a “show and tell” presentation livestreamed Wednesday night, Musk said his team is in the process of asking U.S. regulators to allow them to test the device. He said he thinks the company should be able to put the implant in a human brain as part of a clinical trial in about six months, though that timeline is far from certain.

Musk’s Neuralink is one of many groups working on linking brains to computers, efforts aimed at helping treat brain disorders, overcoming brain injuries and other applications.

The field dates back to the 1960s, said Rajesh Rao, co-director of the Center for Neurotechnology at the University of Washington. “But it really took off in the 90s. And more recently we’ve seen lots of advances, especially in the area of communication brain computer interfaces.”

Rao, who watched Musk’s presentation online, said he doesn’t think Neuralink is ahead of the pack in terms of brain-computer interface achievements. “But ... they are quite ahead in terms of the actual hardware in the devices,” he said.

The Neuralink device is about the size of a large coin and is designed to be implanted in the skull, with ultra-thin wires going directly into the brain. Musk said the first two applications in people would be restoring vision and helping people with little or no ability to operate their muscles rapidly use digital devices.

He said he also envisions that in someone with a broken neck, signals from the brain could be bridged to Neuralink devices in the spinal cord.

“We’re confident there are no physical limitations to enabling full body functionality,” said Musk, who recently took over Twitter and is the CEO of Tesla and SpaceX.

In experiments by other teams, implanted sensors have let paralyzed people use brain signals to operate computers and move robotic arms. In a 2018 study in the journal PLOS ONE, three participants with paralysis below the neck affecting all of their limbs used an experimental brain-computer interface being tested by the consortium BrainGate. The interface records neural activity from a small sensor in the brain to navigate things like email and apps.


A r ecent study in the journal Nature, by scientists at the Swiss research center NeuroRestore, identified a type of neuron activated by electrical stimulation of the spinal cord, allowing nine patients with chronic spinal cord injury to walk again.

Researchers have also been working on brain and machine interfaces for restoring vision. Rao said some companies have developed retinal implants, but Musk’s announcement suggested his team would use signals directly targeting the brain's visual cortex, an approach that some academic groups are also pursuing, “with limited success.”

Neuralink spokespeople did not immediately respond to an email to the press office. Dr. Jaimie Henderson, a neurosurgery professor at Stanford University who is an adviser for Neuralink, said one way Neuralink is different than some other devices is that it has the ability to reach into deeper layers of the brain. But he added: “There are lots of different systems that have lots of different advantages.”

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

Should you invest $1,000 in Tesla right now?

Before you consider Tesla, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tesla wasn't on the list.

While Tesla currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Tesla (TSLA)
4.63 of 5 stars
$156.86-2.9%N/A36.39Reduce$198.81
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

The Tesla Earnings Story That's NOT Being Told

The Tesla Earnings Story That's NOT Being Told

If the last year of price cuts and sluggish sales weren’t enough to tip off the market to the fact the EV bubble has burst, Tesla’s NASDAQ: TSLA Q4 results and outlook for 2024 should do it.

Search Headlines: